Influenza Vaccination Guidelines and Vaccine Sales in Southeast Asia: 2008-2011. Gupta, V., Dawood, F. S., Muangchana, C., Lan, P. T., Xeuatvongsa, A., Sovann, L., Olveda, R., Cutter, J., Oo, K. Y., Ratih, T. S. D., Kheong, C. C., Kapella, B. K., Kitsutani, P., Corwin, A., & Olsen, S. J. PLoS ONE, 7(12):e52842, 2012. ![Influenza Vaccination Guidelines and Vaccine Sales in Southeast Asia: 2008-2011 [link]](https://bibbase.org/img/filetypes/link.svg "link")
Paper doi abstract bibtex Background: Southeast Asia is a region with great potential for the emergence of a pandemic influenza virus. Global efforts to improve influenza surveillance in this region have documented the burden and seasonality of influenza viruses and have informed influenza prevention strategies, but little information exists about influenza vaccination guidelines and vaccine sales. Method(s): To ascertain the existence of influenza vaccine guidelines and define the scope of vaccine sales, we sent a standard three-page questionnaire to the ten member nations of the Association of Southeast Asian Nations. We also surveyed three multinational manufacturers who supply influenza vaccines in the region. Result(s): Vaccine sales in the private sector were \textless1000 per 100,000 population in the 10 countries. Five countries reported purchasing vaccine for use in the public sector. In 2011, Thailand had the highest combined reported rate of vaccine sales (10,333 per 100,000). In the 10 countries combined, the rate of private sector sales during 2010-2011 (after the A(H1N1)2009pdm pandemic) exceeded 2008 pre-pandemic levels. Five countries (Indonesia, Malaysia, Singapore, Thailand and Vietnam) had guidelines for influenza vaccination but only two were consistent with global guidelines. Four recommended vaccination for health care workers, four for elderly persons, three for young children, three for persons with underlying disease, and two for pregnant women. Conclusion(s): The rate of vaccine sales in Southeast Asia remains low, but there was a positive impact in sales after the A(H1N1)2009pdm pandemic. Low adherence to global vaccine guidelines suggests that more work is needed in the policy arena.
@article{gupta_influenza_2012,
title = {Influenza {Vaccination} {Guidelines} and {Vaccine} {Sales} in {Southeast} {Asia}: 2008-2011},
volume = {7},
issn = {1932-6203 (electronic) 1932-6203},
url = {http://www.plosone.org/article/fetchObjectAttachment.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0052842&representation=PDF http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=366307846},
doi = {10.1371/journal.pone.0052842},
abstract = {Background: Southeast Asia is a region with great potential for the emergence of a pandemic influenza virus. Global efforts to improve influenza surveillance in this region have documented the burden and seasonality of influenza viruses and have informed influenza prevention strategies, but little information exists about influenza vaccination guidelines and vaccine sales. Method(s): To ascertain the existence of influenza vaccine guidelines and define the scope of vaccine sales, we sent a standard three-page questionnaire to the ten member nations of the Association of Southeast Asian Nations. We also surveyed three multinational manufacturers who supply influenza vaccines in the region. Result(s): Vaccine sales in the private sector were {\textless}1000 per 100,000 population in the 10 countries. Five countries reported purchasing vaccine for use in the public sector. In 2011, Thailand had the highest combined reported rate of vaccine sales (10,333 per 100,000). In the 10 countries combined, the rate of private sector sales during 2010-2011 (after the A(H1N1)2009pdm pandemic) exceeded 2008 pre-pandemic levels. Five countries (Indonesia, Malaysia, Singapore, Thailand and Vietnam) had guidelines for influenza vaccination but only two were consistent with global guidelines. Four recommended vaccination for health care workers, four for elderly persons, three for young children, three for persons with underlying disease, and two for pregnant women. Conclusion(s): The rate of vaccine sales in Southeast Asia remains low, but there was a positive impact in sales after the A(H1N1)2009pdm pandemic. Low adherence to global vaccine guidelines suggests that more work is needed in the policy arena.},
language = {English},
number = {12},
journal = {PLoS ONE},
author = {Gupta, V. and Dawood, F. S. and Muangchana, C. and Lan, P. T. and Xeuatvongsa, A. and Sovann, L. and Olveda, R. and Cutter, J. and Oo, K. Y. and Ratih, T. S. D. and Kheong, C. C. and Kapella, B. K. and Kitsutani, P. and Corwin, A. and Olsen, S. J.},
year = {2012},
keywords = {*drug marketing, *influenza vaccination, *influenza vaccine, *practice guideline, Brunei Darussalam, Cambodia, Indonesia, Laos, Malaysia, Myanmar, Philippines, Singapore, Thailand, Viet Nam, article, child care, controlled study, drug use, elderly care, health care personnel, health care survey, health program, human, pandemic, pregnant woman, questionnaire},
pages = {e52842},
}
Downloads: 0
{"_id":"5Q3bKrcejNrj53YD4","bibbaseid":"gupta-dawood-muangchana-lan-xeuatvongsa-sovann-olveda-cutter-etal-influenzavaccinationguidelinesandvaccinesalesinsoutheastasia20082011-2012","author_short":["Gupta, V.","Dawood, F. S.","Muangchana, C.","Lan, P. T.","Xeuatvongsa, A.","Sovann, L.","Olveda, R.","Cutter, J.","Oo, K. Y.","Ratih, T. S. D.","Kheong, C. C.","Kapella, B. K.","Kitsutani, P.","Corwin, A.","Olsen, S. J."],"bibdata":{"bibtype":"article","type":"article","title":"Influenza Vaccination Guidelines and Vaccine Sales in Southeast Asia: 2008-2011","volume":"7","issn":"1932-6203 (electronic) 1932-6203","url":"http://www.plosone.org/article/fetchObjectAttachment.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0052842&representation=PDF http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=366307846","doi":"10.1371/journal.pone.0052842","abstract":"Background: Southeast Asia is a region with great potential for the emergence of a pandemic influenza virus. Global efforts to improve influenza surveillance in this region have documented the burden and seasonality of influenza viruses and have informed influenza prevention strategies, but little information exists about influenza vaccination guidelines and vaccine sales. Method(s): To ascertain the existence of influenza vaccine guidelines and define the scope of vaccine sales, we sent a standard three-page questionnaire to the ten member nations of the Association of Southeast Asian Nations. We also surveyed three multinational manufacturers who supply influenza vaccines in the region. Result(s): Vaccine sales in the private sector were \\textless1000 per 100,000 population in the 10 countries. Five countries reported purchasing vaccine for use in the public sector. In 2011, Thailand had the highest combined reported rate of vaccine sales (10,333 per 100,000). In the 10 countries combined, the rate of private sector sales during 2010-2011 (after the A(H1N1)2009pdm pandemic) exceeded 2008 pre-pandemic levels. Five countries (Indonesia, Malaysia, Singapore, Thailand and Vietnam) had guidelines for influenza vaccination but only two were consistent with global guidelines. Four recommended vaccination for health care workers, four for elderly persons, three for young children, three for persons with underlying disease, and two for pregnant women. Conclusion(s): The rate of vaccine sales in Southeast Asia remains low, but there was a positive impact in sales after the A(H1N1)2009pdm pandemic. Low adherence to global vaccine guidelines suggests that more work is needed in the policy arena.","language":"English","number":"12","journal":"PLoS ONE","author":[{"propositions":[],"lastnames":["Gupta"],"firstnames":["V."],"suffixes":[]},{"propositions":[],"lastnames":["Dawood"],"firstnames":["F.","S."],"suffixes":[]},{"propositions":[],"lastnames":["Muangchana"],"firstnames":["C."],"suffixes":[]},{"propositions":[],"lastnames":["Lan"],"firstnames":["P.","T."],"suffixes":[]},{"propositions":[],"lastnames":["Xeuatvongsa"],"firstnames":["A."],"suffixes":[]},{"propositions":[],"lastnames":["Sovann"],"firstnames":["L."],"suffixes":[]},{"propositions":[],"lastnames":["Olveda"],"firstnames":["R."],"suffixes":[]},{"propositions":[],"lastnames":["Cutter"],"firstnames":["J."],"suffixes":[]},{"propositions":[],"lastnames":["Oo"],"firstnames":["K.","Y."],"suffixes":[]},{"propositions":[],"lastnames":["Ratih"],"firstnames":["T.","S.","D."],"suffixes":[]},{"propositions":[],"lastnames":["Kheong"],"firstnames":["C.","C."],"suffixes":[]},{"propositions":[],"lastnames":["Kapella"],"firstnames":["B.","K."],"suffixes":[]},{"propositions":[],"lastnames":["Kitsutani"],"firstnames":["P."],"suffixes":[]},{"propositions":[],"lastnames":["Corwin"],"firstnames":["A."],"suffixes":[]},{"propositions":[],"lastnames":["Olsen"],"firstnames":["S.","J."],"suffixes":[]}],"year":"2012","keywords":"*drug marketing, *influenza vaccination, *influenza vaccine, *practice guideline, Brunei Darussalam, Cambodia, Indonesia, Laos, Malaysia, Myanmar, Philippines, Singapore, Thailand, Viet Nam, article, child care, controlled study, drug use, elderly care, health care personnel, health care survey, health program, human, pandemic, pregnant woman, questionnaire","pages":"e52842","bibtex":"@article{gupta_influenza_2012,\n\ttitle = {Influenza {Vaccination} {Guidelines} and {Vaccine} {Sales} in {Southeast} {Asia}: 2008-2011},\n\tvolume = {7},\n\tissn = {1932-6203 (electronic) 1932-6203},\n\turl = {http://www.plosone.org/article/fetchObjectAttachment.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0052842&representation=PDF http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=366307846},\n\tdoi = {10.1371/journal.pone.0052842},\n\tabstract = {Background: Southeast Asia is a region with great potential for the emergence of a pandemic influenza virus. Global efforts to improve influenza surveillance in this region have documented the burden and seasonality of influenza viruses and have informed influenza prevention strategies, but little information exists about influenza vaccination guidelines and vaccine sales. Method(s): To ascertain the existence of influenza vaccine guidelines and define the scope of vaccine sales, we sent a standard three-page questionnaire to the ten member nations of the Association of Southeast Asian Nations. We also surveyed three multinational manufacturers who supply influenza vaccines in the region. Result(s): Vaccine sales in the private sector were {\\textless}1000 per 100,000 population in the 10 countries. Five countries reported purchasing vaccine for use in the public sector. In 2011, Thailand had the highest combined reported rate of vaccine sales (10,333 per 100,000). In the 10 countries combined, the rate of private sector sales during 2010-2011 (after the A(H1N1)2009pdm pandemic) exceeded 2008 pre-pandemic levels. Five countries (Indonesia, Malaysia, Singapore, Thailand and Vietnam) had guidelines for influenza vaccination but only two were consistent with global guidelines. Four recommended vaccination for health care workers, four for elderly persons, three for young children, three for persons with underlying disease, and two for pregnant women. Conclusion(s): The rate of vaccine sales in Southeast Asia remains low, but there was a positive impact in sales after the A(H1N1)2009pdm pandemic. Low adherence to global vaccine guidelines suggests that more work is needed in the policy arena.},\n\tlanguage = {English},\n\tnumber = {12},\n\tjournal = {PLoS ONE},\n\tauthor = {Gupta, V. and Dawood, F. S. and Muangchana, C. and Lan, P. T. and Xeuatvongsa, A. and Sovann, L. and Olveda, R. and Cutter, J. and Oo, K. Y. and Ratih, T. S. D. and Kheong, C. C. and Kapella, B. K. and Kitsutani, P. and Corwin, A. and Olsen, S. J.},\n\tyear = {2012},\n\tkeywords = {*drug marketing, *influenza vaccination, *influenza vaccine, *practice guideline, Brunei Darussalam, Cambodia, Indonesia, Laos, Malaysia, Myanmar, Philippines, Singapore, Thailand, Viet Nam, article, child care, controlled study, drug use, elderly care, health care personnel, health care survey, health program, human, pandemic, pregnant woman, questionnaire},\n\tpages = {e52842},\n}\n\n","author_short":["Gupta, V.","Dawood, F. S.","Muangchana, C.","Lan, P. T.","Xeuatvongsa, A.","Sovann, L.","Olveda, R.","Cutter, J.","Oo, K. Y.","Ratih, T. S. D.","Kheong, C. C.","Kapella, B. K.","Kitsutani, P.","Corwin, A.","Olsen, S. J."],"key":"gupta_influenza_2012","id":"gupta_influenza_2012","bibbaseid":"gupta-dawood-muangchana-lan-xeuatvongsa-sovann-olveda-cutter-etal-influenzavaccinationguidelinesandvaccinesalesinsoutheastasia20082011-2012","role":"author","urls":{"Paper":"http://www.plosone.org/article/fetchObjectAttachment.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0052842&representation=PDF http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=366307846"},"keyword":["*drug marketing","*influenza vaccination","*influenza vaccine","*practice guideline","Brunei Darussalam","Cambodia","Indonesia","Laos","Malaysia","Myanmar","Philippines","Singapore","Thailand","Viet Nam","article","child care","controlled study","drug use","elderly care","health care personnel","health care survey","health program","human","pandemic","pregnant woman","questionnaire"],"metadata":{"authorlinks":{}}},"bibtype":"article","biburl":"https://bibbase.org/zotero/vincentwntu","dataSources":["icTw8KRRMMANXJHRd"],"keywords":["*drug marketing","*influenza vaccination","*influenza vaccine","*practice guideline","brunei darussalam","cambodia","indonesia","laos","malaysia","myanmar","philippines","singapore","thailand","viet nam","article","child care","controlled study","drug use","elderly care","health care personnel","health care survey","health program","human","pandemic","pregnant woman","questionnaire"],"search_terms":["influenza","vaccination","guidelines","vaccine","sales","southeast","asia","2008","2011","gupta","dawood","muangchana","lan","xeuatvongsa","sovann","olveda","cutter","oo","ratih","kheong","kapella","kitsutani","corwin","olsen"],"title":"Influenza Vaccination Guidelines and Vaccine Sales in Southeast Asia: 2008-2011","year":2012}